Citations

Mayo Clinic

Showing 10 of 108599 citations.

The Influence of Word Frequency on Word Retrieval: Measuring Covert Behaviors
Chih, Yu-Chun, Stierwalt, Julie A. G., LaPointe, Leonard L., Chih, Yu-Pin, Chih, Yu-Pin, Chih, Yu‐Chun , Chih, Yu-Pin, Chih, Yu-Pin

Communication Disorders Quarterly | May 27, 2017 | Volume: 39 | Issue: 1 | Pages: 288-292

10.1177/1525740116686311 Get It

Physiological activities (heart rate and respiratory rate) during a word retrieval task were measured in normal participants. Word frequency demonstrated a significant effect on naming accuracy and latencies but not on physiological activities. These data will serve as a basis for comparison for individuals with a compromised language system.
BCL6 represses antiviral resistance in follicular T helper cells
Amet, Tohti, Son, Young Min , Jiang, Li , Cheon, In Su , Huang, Su, Gupta, Samir K. , Montaner, Luis J. , Yu, Qigui , Dent, Alexander L. , Sun, Jie

Journal of Leukocyte Biology | May 27, 2017 | Volume: 102 | Issue: 2 | Pages: 527-536

10.1189/jlb.4a1216-513rr | PMID 28550121 Get It

Abstract Follicular Th (Tfh) cells are a distinct subset of Th cells that help B cells produce class-switched antibodies. Studies have demonstrated that Tfh cells are highly prone to HIV infection and replication. However, the molecular mechanisms underlying this phenomenon are largely unclear. Here, we show that murine and human Tfh cells have diminished constitutive expression of IFN-stimulated genes (ISGs) inclusive of antiviral resistance factor MX dynamin-like GTPase 2 (MX2) and IFN-induced transmembrane 3 (IFITM3) compared with non-Tfh cells. A lower antiviral resistance in Tfh was consistent with a higher susceptibility to retroviral infections. Mechanistically, we found that BCL6, a master regulator of Tfh cell development, binds to ISG loci and inhibits the expression of MX2 and IFITM3 in Tfh cells. We demonstrate further that inhibition of the BCL6 BR-C, ttk, and bab (BTB) domain function increases the expression of ISGs and suppresses HIV infection and replication in Tfh cells. Our data reveal a regulatory role of BCL6 in inhibiting antiviral resistance factors in Tfh cells, thereby promoting the susceptibility Tfh cells to viral infections. Our results indicate that the modulation of BCL6 function in Tfh cells could be a potential strategy to enhance Tfh cell resistance to retroviral infections and potentially decrease cellular reservoirs of HIV infection.
Risk of Severe Hypoglycemia in Type 1 Diabetes Over 30 Years of Follow-up in the DCCT/EDIC Study
Gubitosi‐Klug, Rose , Braffett, Barbara H. , White, Neil H. , Sherwin, Robert S., Service, F. John, Lachin, John M. , Tamborlane, William V. , Gubitosi-Klug, Rose A

Diabetes Care | May 27, 2017 | Volume: 40 | Issue: 8 | Pages: 1010-1016

10.2337/dc16-2723 | PMID 28550194 Get It

OBJECTIVE During the Diabetes Control and Complications Trial (DCCT), intensive diabetes therapy achieving a mean HbA1c of ∼7% was associated with a threefold increase in the rate of severe hypoglycemia (defined as requiring assistance) compared with conventional diabetes therapy with a mean HbA1c of 9% (61.2 vs. 18.7 per 100 patient-years). After ∼30 years of follow-up, we investigated the rates of severe hypoglycemia in the DCCT/Epidemiology of Diabetes Inverventions and Complications (EDIC) cohort. RESEARCH DESIGN AND METHODS Rates of severe hypoglycemia were reported quarterly during DCCT and annually during EDIC (i.e., patient recall of episodes in the preceding 3 months). Risk factors influencing the rate of severe hypoglycemia over time were investigated. RESULTS One-half of the DCCT/EDIC cohort reported episodes of severe hypoglycemia. During EDIC, rates of severe hypoglycemia fell in the former DCCT intensive treatment group but rose in the former conventional treatment group, resulting in similar rates (40.8 vs. 36.6 episodes per 100 patient-years, respectively) with a relative risk of 1.12 (95% CI 0.91–1.37). A preceding episode of severe hypoglycemia was the most powerful predictor of subsequent episodes. Entry into the DCCT study as an adolescent was associated with an increased risk of severe hypoglycemia, whereas insulin pump use was associated with a lower risk. Severe hypoglycemia rates increased with lower HbA1c similarly among participants in both treatment groups. CONCLUSIONS Rates of severe hypoglycemia have equilibrated over time between the two DCCT/EDIC treatment groups in association with advancing duration of diabetes and similar HbA1c levels. Severe hypoglycemia persists and remains a challenge for patients with type 1 diabetes across their life span.
Atrial Natriuretic Peptide ― Old But New Therapeutic in Cardiovascular Diseases ―
Ichiki, Tomoko , Burnett, John C.

Circulation Journal | May 26, 2017 | Volume: 81 | Issue: 7 | Pages: 913-919

10.1253/circj.cj-17-0499 | PMID 28552863 Get It

Recommendations on the use of magnetic resonance imaging in PSC‐A position statement from the International PSC Study Group
Eaton, John E. , Ringe, Kristina I. , Venkatesh, Sudhakar K. , Yamamura, Jin , IPSCSG, for the MRI working group of the, Eaton, John, Venkatesh, Sudhakar, Schramm, Christoph , IPSCSG, for the MRI working group of the, Venkatesh, Sudhakar K

Hepatology | May 26, 2017 | Volume: 66 | Issue: 5 | Pages: 1675-1688

10.1002/hep.29293 | PMID 28555945 Get It

Primary sclerosing cholangitis (PSC) is a chronic cholestatic liver disorder characterized by inflammation and fibrosis of the intra‐ and/or extrahepatic bile ducts. Magnetic resonance imaging (MRI) is a noninvasive imaging modality that can be used to diagnose PSC and detect disease related complications. Quantitative MRI technologies also have the potential to provide valuable prognostic information. Despite the potential of this imaging technology, the clinical application of MRI in the care of PSC patients and imaging standards vary across institutions. Moreover, a unified position statement about the role of MRI in the care of PSC patients, quality imaging standards, and its potential as a research tool is lacking. Conclusion : Members of the International PSC Study Group and radiologists from North America and Europe have compiled the following position statement to provide guidance regarding the application of MRI in the care of PSC patients, minimum imaging standards, and future areas of research. (H epatology 2017;66:1675–1688).
Serum extracellular vesicles contain protein biomarkers for primary sclerosing cholangitis and cholangiocarcinoma
Arbelaiz, Ander, Azkargorta, Mikel , Krawczyk, Marcin , Santos‐Laso, Álvaro , Lapitz, Ainhoa , Perugorria, María J. , González, Esperanza , Jiménez-Agüero, Raúl , Casta, Adelaida La , Ibarra, Cesar , Sanchez‐Campos, Alberto, Jimeno, J.P., Lammert, Frank , Milkiewicz, Piotr , Marzioni, Marco , Marı́n, José J.G. , Martínez, I. Mascarell, Elortza, Félix , Falcón‐Pérez, Juan Manuel , Bujanda, Luís , Bañales, Jesús M. , Erice, Oihane , Macı́as, Rocı́o I.R. , Patel, Tushar , Gores, Gregory J. , Marzioni, Marco , Banales, Jesus M , Falcón-Perez, Juan Manual , Milkiewicz, Piotr , Bujanda, L.

Hepatology | May 26, 2017 | Volume: 66 | Issue: 4 | Pages: 1125-1143

10.1002/hep.29291 | PMID 28555885 Get It

Cholangiocarcinoma (CCA) includes a heterogeneous group of biliary cancers with poor prognosis. Several conditions, such as primary sclerosing cholangitis (PSC), are risk factors. Noninvasive differential diagnosis between intrahepatic CCA and hepatocellular carcinoma (HCC) is sometimes difficult. Accurate noninvasive biomarkers for PSC, CCA, and HCC are not available. In the search for novel biomarkers, serum extracellular vesicles (EV) were isolated from CCA (n = 43), PSC (n = 30), or HCC (n = 29) patients and healthy individuals (control, n = 32); and their protein content was characterized. By using nanoparticle tracking analysis, serum EV concentration was found to be higher in HCC than in all the other groups. Round morphology (by transmission electron microscopy), size (∼180 nm diameter by nanoparticle tracking analysis), and markers (clusters of differentiation 9, 63, and 81 by immunoblot) indicated that most serum EV were exosomes. Proteome profiles (by mass spectrometry) revealed multiple differentially expressed proteins among groups. Several of these proteins showed high diagnostic values with maximum area under the receiver operating characteristic curve of 0.878 for CCA versus control, 0.905 for CCA stage I‐II versus control, 0.789 for PSC versus control, 0.806 for noncirhottic PSC versus control, 0.796 for CCA versus PSC, 0.956 for CCA stage I‐II versus PSC, 0.904 for HCC versus control, and 0.894 for intrahepatic CCA versus HCC. Proteomic analysis of EV derived from CCA human cells in vitro revealed higher abundance of oncogenic proteins compared to EV released by normal human cholangiocytes. Orthotopic implant of CCA human cells in the liver of immunodeficient mice resulted in the release to serum of EV containing some similar human oncogenic proteins. Conclusion : Proteomic signatures found in serum EV of CCA, PSC, and HCC patients show potential usefulness as diagnostic tools. (H epatology 2017;66:1125‐1143).
A phase 1/2 study of the oral proteasome inhibitor ixazomib in relapsed or refractory AL amyloidosis
Palladini, Giovanni , Kukreti, Vishal , Zonder, Jeffrey A. , Cohen, Adam D. , Seldin, David C. , Schönland, Stefan , Berg, Deborah, Yang, Huyuan, Gupta, Neeraj , Hui, Ai-Min, Comenzo, Raymond L. , Merlini, Giampaolo , Sanchorawala, Vaishali , Dispenzieri, Angela , Jaccard, Arnaud , Gupta, Neeraj , Merlini, Giampaolo , Cohen, Adam D , Schönland, Stefan , Palladini, Giovanni

Blood | May 26, 2017 | Volume: 130 | Issue: 5 | Pages: 597-605

10.1182/blood-2017-03-771220 | PMID 28550039 Get It

Abstract This phase 1/2 study assessed the safety, tolerability, and preliminary efficacy of the oral proteasome inhibitor (PI) ixazomib in patients with relapsed/refractory immunoglobulin light chain (AL) amyloidosis. Ixazomib was administered to adult patients with relapsed/refractory AL amyloidosis after 1 or more prior lines of therapy (including bortezomib) on days 1, 8, and 15 of 28-day cycles, for up to 12 cycles. Patients with less than partial response after 3 cycles received oral dexamethasone (40 mg, days 1-4) from cycle 4. A 3+3 dose-escalation phase was followed by 2 expansion cohorts (PI-naive and PI-exposed patients) at the maximum tolerated dose (MTD). Twenty-seven patients were enrolled: 11 during dose escalation (6 at 4.0 mg and 5 at 5.5 mg) and 16 during dose expansion (4.0 mg). Three patients experienced dose-limiting toxicities: 1 at 4.0 mg and 2 at 5.5 mg; the MTD was determined as 4.0 mg. Most common adverse events (AEs) included nausea, skin and subcutaneous tissue disorders (SSTD), diarrhea, and fatigue; grade 3 or higher AEs included dyspnea, fatigue, and SSTD. Overall, the hematologic response rate was 52% in patients treated at the MTD (n = 21). Organ responses were seen in 56% of patients (5 cardiac, 5 renal). Median hematologic progression-free survival was 14.8 months; 1-year progression-free and overall survival rates were 60% and 85%, respectively (median follow-up, 16.9 months). Weekly oral ixazomib appears to be active in patients with relapsed/refractory AL amyloidosis, with a generally manageable safety profile. The study was registered at clinicaltrials.gov as #NCT01318902. A phase 3 study is ongoing (#NCT01659658).
Experimental cardiac radiation exposure induces ventricular diastolic dysfunction with preserved ejection fraction
Saiki, Hirofumi , Moulay, Gilles , Guenzel, Adam J. , Decklever, Teresa, Classic, Kelly, Pham, Linh , Chen, Horng H. , Burnett, John C. , Russell, Stephen J. , Redfield, Margaret M. , Liu, Weibin , Decklever, Teresa D, Classic, Kelly L, Liu, Weibin , Russell, Stephen J

American Journal of Physiology-Heart and Circulatory Physiology | May 26, 2017 | Volume: 313 | Issue: 2 | Pages: H392-H407

10.1152/ajpheart.00124.2017 | PMID 28550173 Get It

Breast cancer radiotherapy increases the risk of heart failure with preserved ejection fraction (HFpEF). Cardiomyocytes are highly radioresistant, but radiation specifically affects coronary microvascular endothelial cells, with subsequent microvascular inflammation and rarefaction. The effects of radiation on left ventricular (LV) diastolic function are poorly characterized. We hypothesized that cardiac radiation exposure may result in diastolic dysfunction without reduced EF. Global cardiac expression of the sodium-iodide symporter (NIS) was induced by cardiotropic gene (adeno-associated virus serotype 9) delivery to 5-wk-old rats. SPECT/CT (125I) measurement of cardiac iodine uptake allowed calculation of the 131I doses needed to deliver 10- or 20-Gy cardiac radiation at 10 wk of age. Radiated (Rad; 10 or 20 Gy) and control rats were studied at 30 wk of age. Body weight, blood pressure, and heart rate were similar in control and Rad rats. Compared with control rats, Rad rats had impaired exercise capacity, increased LV diastolic stiffness, impaired LV relaxation, and elevated filling pressures but similar LV volume, EF, end-systolic elastance, preload recruitable stroke work, and peak +dP/d t. Pathology revealed reduced microvascular density, mild concentric cardiomyocyte hypertrophy, and increased LV fibrosis in Rad rats compared with control rats. In the Rad myocardium, oxidative stress was increased and in vivo PKG activity was decreased. Experimental cardiac radiation exposure resulted in diastolic dysfunction without reduced EF. These data provide insight into the association between cardiac radiation exposure and HFpEF risk and lend further support for the importance of inflammation-related coronary microvascular compromise in HFpEF. NEW & NOTEWORTHY Cardiac radiation exposure during radiotherapy increases the risk of heart failure with preserved ejection fraction. In a novel rodent model, cardiac radiation exposure resulted in coronary microvascular rarefaction, oxidative stress, impaired PKG signaling, myocardial fibrosis, mild cardiomyocyte hypertrophy, left ventricular diastolic dysfunction, and elevated left ventricular filling pressures despite preserved ejection fraction.
Cortical Thickness and Depressive Symptoms in Cognitively Normal Individuals: The Mayo Clinic Study of Aging
Pink, Anna , Przybelski, Scott A. , Stokin, Gorazd B. , Roberts, Rosebud O., Mielke, Michelle M. , Jack, Clifford R. , Petersen, Ronald C. , Geda, Yonas E. , Krell-Roesch, Janina, Krell‐Roesch, Janina , Knopman, David S. , Jack, Clifford R , Mielke, Michelle M , Geda, Yonas E , Stokin, Gorazd

Journal of Alzheimer’s Disease | May 26, 2017 | Volume: 58 | Issue: 4 | Pages: 1273-1281

10.3233/jad-170041 | PMID 28550256 Get It

Altered cortical thickness has been observed in aging and various neurodegenerative disorders. Furthermore, reduced hippocampal volume has been reported in late-life depression. Even mild depressive symptoms are common in the elderly. However, little is known about the structural MRI measures of depressive symptoms in normal cognitive aging. Thus we sought to examine the association between depressive symptoms with cortical thickness and hippocampal volume as measured by brain MRI among community-dwelling participants. We conducted a cross-sectional study derived from the ongoing population-based Mayo Clinic Study of Aging, involving cognitively normal participants ( N = 1,507) aged≥70 years. We observed that depressive symptoms were associated with lower global cortical thickness and lower thickness in specific prefrontal and temporal cortical regions, labeled by FreeSurfer software, version 5.3. As expected, the strength of correlation was very small, given that participants were community-dwelling with only mild depressive symptoms. We did not observe associations between hippocampal volume and depressive symptoms. These findings may provide insight into the structural correlates of mild depressive symptoms in elderly participants.
Distinctive microbiomes and metabolites linked with weight loss after gastric bypass, but not gastric banding
Ilhan, Zehra Esra , DiBaise, John K. , Hoyt, David , Marcus, Andrew K. , Krajmalnik‐Brown, Rosa , Hoyt, David W , Isern, Nancy , Kang, Dae‐Wook , Crowell, Michael D. , Rittmann, Bruce E.

The ISME Journal | May 26, 2017 | Volume: 11 | Issue: 9 | Pages: 2047-2058

10.1038/ismej.2017.71 | PMID 28548658 Get It

Abstract Roux-en-Y gastric bypass (RYGB) and laparoscopic adjustable gastric banding (LAGB) are anatomically different bariatric operations. RYGB achieves greater weight loss compared with LAGB. Changes in the gut microbiome have been documented after RYGB, but not LAGB, and the microbial contribution to sustainable surgical weight loss warrants further evaluation. We hypothesized that RYGB imposes greater changes on the microbiota and its metabolism than LAGB, and that the altered microbiota may contribute to greater weight loss. Using multi-omic approaches, we analyzed fecal microbial community structure and metabolites of pre-bariatric surgery morbidly obese (PreB-Ob), normal weight (NW), post-RYGB, and post-LAGB participants. RYGB microbiomes were significantly different from those from NW, LAGB and PreB-Ob. Microbiome differences between RYGB and PreB-Ob populations were mirrored in their metabolomes. Diversity was higher in RYGB compared with LAGB, possibly because of an increase in the abundance of facultative anaerobic, bile-tolerant and acid-sensible microorganisms in the former. Possibly because of lower gastric acid exposure, phylotypes from the oral cavity, such as Escherichia, Veillonella and Streptococcus, were in greater abundance in the RYGB group, and their abundances positively correlated with percent excess weight loss. Many of these post-RYGB microorganisms are capable of amino-acid fermentation. Amino-acid and carbohydrate fermentation products—isovalerate, isobutyrate, butyrate and propionate—were prevalent in RYGB participants, but not in LAGB participants. RYGB resulted in greater alteration of the gut microbiome and metabolome than LAGB, and RYGB group exhibited unique microbiome composed of many amino-acid fermenters, compared with nonsurgical controls.